The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy


Atasoy B. M. , Yonal O., Demirel B., DANE F. , YILMAZ Y. , Kalayci C., ...More

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, vol.269, no.1, pp.275-282, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 269 Issue: 1
  • Publication Date: 2012
  • Doi Number: 10.1007/s00405-010-1477-7
  • Title of Journal : EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
  • Page Numbers: pp.275-282
  • Keywords: Chemoradiotherapy, Enteral nutrition, Gastrostomy, Head and neck neoplasms, QUALITY-OF-LIFE, WEIGHT-LOSS, CONCOMITANT CHEMORADIOTHERAPY, STAGE-III, RADIOTHERAPY, PREDICTORS, CARCINOMA, TUBES, INTERVENTION, CHEMOTHERAPY

Abstract

To investigate the impact of early insertion of percutaneous endoscopic gastrostomy-tube on nutritional status and completeness of concurrent chemotherapy in locally advanced head and neck cancer patients treated with chemoradiotherapy. Twenty-three patients were enrolled into this prospective study. Gastrostomy-tube was inserted in patients before the initiation of chemoradiotherapy. There was not any significant change in nutritional parameters of patients that used their tube during treatment. Despite the grade 3 mucositis, the planned concurrent chemotherapy could be given in 70% of the patients. However, nine patients had weak compliance and their body weight (P = 0.01) and body mass index (P = 0.01) deteriorated in the first 4 weeks of chemoradiotherapy. The completeness of concurrent chemo-rate was 44% in these patients. Toxicity, requiring aggressive supportive care, may limit the chemotherapy part of curative concomitant chemoradiotherapy. By providing adequate enteral nutrition the insertion of gastrostomy-tube can increase the completeness rate of concurrent chemotherapy.